Kacper Polcodecom
Reviews 1

I recently had the opportunity to work with a company in the field of cancer research. They have exceptional products and a great team. I was impressed by their commitment to the cause and the impact they are making. Highly recommend!

Katherine McIntosh
Reviews 1

Oncurious nv is doing an incredible job in the field of cancer research. Their commitment to finding innovative solutions is commendable. The team is knowledgeable, dedicated, and passionate. I highly recommend their products!

Charlie Sankovich
Reviews 1

Oncurious nv is an excellent company with amazing products and a fantastic team. They have truly revolutionized the field of cancer research. The dedication and passion of everyone at Oncurious nv is inspiring. I cannot recommend them enough!

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="oncurious-nv" data-lang="en"></div>
More widgets

About Oncurious nv

Oncurious NV is a Belgium-based biotech company focusing on the development of innovative oncology treatments. Oncurious NV was incorporated in April 2015. Shareholders are Oxurion NV, an integrated biopharmaceutical company focused on developing and commercializing ophthalmic medicines, and VIB, the leading life sciences institute in Flanders (Belgium). In February 2013, a paper in Cell (Cell, 152, 1065-76, 2013) highlighted for the first time that PlGF – placental growth factor – plays a vital role in the brain. Its expression is required for the growth and spread of medulloblastoma, a rare, life-threatening brain tumor that mainly affects children. The paper was based on pre-clinical research conducted by Prof. Rakesh Jain from the Massachusetts General Hospital at Harvard (Boston) and the research team of Prof. Peter Carmeliet from VIB/ KU Leuven.

Categories
Pharmaceuticals